HOME >> MEDICINE >> NEWS
New anti-angiogenic proteins discovered

Scientists at UCLA and Human Genome Sciences report discovery of two human proteins, METH-1 and METH-2, that inhibit blood vessel formation

More potent than endostatin, with potential for treating a range of cancer tumors

A team of scientists working at UCLA and Human Genome Sciences (NASDAQ: HGSI) discovered two human proteins that inhibit the formation of new blood vessels and have potential for treating cancer through suppression of tumor growth.

The two proteins, named METH-1 and METH-2, were shown to be much more active than endostatin in preventing blood vessel formation and may have applications in creating treatments for a broad range of tumor types.

The discovery of these two proteins and their anti-angiogenic activity is described in the August 13, 1999 issue of Journal of Biological Chemistry. The paper may be accessed at http://www.jbc.org .

The team, led by UCLA molecular biologist Luisa Iruela-Arispe, found that both METH-1 and METH-2 inhibited blood vessel formation in two standard biological model systems, the cornea pocket model and the chorioallontoic membrane model.

The ability of METH-1 and METH-2 to inhibit new blood vessel formation in the cornea pocket model was compared to that of both endostatin and thrombospondin, two other human proteins. The study showed that METH-1 was most potent in inhibiting blood vessel growth, followed by thrombospondin and endostatin.

A solid tumor cannot grow beyond the size of a pinhead unless it has an independent blood supply to deliver the oxygen and nutrients that the malignancy needs to advance and spread. To feed itself, a tumor develops its own blood supply, a process called angiogenesis. Researchers hope anti-angiogenic drugs can interrupt that process, thereby cutting off the blood supply to the tumor and, hopefully, killing it.
'"/>

Contact: Kate de Santis
kate_de_santis@hgsi.com
301-251-6003
Human Genome Sciences, Inc.
5-Aug-1999


Page: 1 2 3 4 5

Related medicine news :

1. Brain synapse formation linked to proteins, Stanford study finds
2. Scientists discover enzyme crucial to the transportation of proteins within cells
3. Uncoupling proteins in human heart
4. Lab studies show two proteins prevented progressive nerve cell loss in Parkinsons disease
5. Unexpected similarities between raindrops and proteins
6. Self-assembling proteins could help repair human tissue
7. New findings on nerve cell proteins show promise for reducing disability
8. C-reactive proteins do not predict early osteoarthritis
9. Two proteins may help prevent Alzheimers brain plaques
10. Cancers love-hate relationship with proteins offers new treatment window
11. Studies show Tim-3 proteins key to immune responses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New anti angiogenic proteins discovered

(Date:7/3/2015)... ... July 03, 2015 , ... ... July 2nd creating a buzz of media attention. In an effort to spread ... HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... speaker lineup for its 2015 Annual Conference , the premiere continuing ... at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... 03, 2015 , ... Smoothies are all the rage right now and all ... quality ingredients. Aurora Natural is proud to introduce a new line of all natural ... antioxidants, vitamins and minerals! , Aurora is offering a variety of blends and stand-alone ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
(Date:7/2/2015)... , July 2, 2015 Pharma Major ... in ZAO "Biocom" in Russia subject ... the Russian pharmaceutical market which recorded RUB 765 billion in ... markets in the world in 2014 (IMS Health). For over ... expected to continue with this trend, projecting Russia ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 /PRNewswire/ ... acquisition of assets related to the ion channel biology ... had previously been obtained as part of Pfizer,s 2011 ... of Pfizer,s rights to the "Icagen" name and trademark. ... provide comprehensive services for ion channel and transporter drug ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
Cached News: